SP-05
Colorectal Cancer (CRC)
PreclinicalNon-clinical trials completed in Japan
Key Facts
Indication
Colorectal Cancer (CRC)
Phase
Preclinical
Status
Non-clinical trials completed in Japan
Company
About Solasia Pharma K.K.
Japanese oncology-focused biopharma company developing and commercializing cancer therapeutics and supportive care products.
View full company profileTherapeutic Areas
Other Colorectal Cancer (CRC) Drugs
| Drug | Company | Phase |
|---|---|---|
| Nadunolimab (CAN04) | Cantargia | Preclinical |
| SENTI-401 | Senti Biosciences | Preclinical |